Clinical Study of a Formulation Containing Phtalox® in Periodontal Disease
Clinical Study of a Formulation Containing Phtalox® for the Prevention and Control of Periodontal Disease
Sponsor: Universidade Federal de Alfenas
Listed as NCT05119283, this NA trial focuses on Bone Loss and Periodontal Diseases and remains completed. Sponsored by Universidade Federal de Alfenas, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2022 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2021 — Dec 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Universidade Federal de Alfenas
For direct contact, visit the study record on ClinicalTrials.gov .